FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

MR Contour DL Model Cleared for Organ Segmentation

FDA clears a GE HealthCare 510(k) for its MR Contour DL, an artificial intelligence model that uses deep learning for organs-at-risk segmentation.

latest-news-card-1
Human Drugs

Agency Accepts Oral Wegovy NDA for Obesity

FDA acccepts for review a Novo Nordisk NDA for a once-daily, 25 mg oral formulation of Wegovy (semaglutide) for chronic weight management in certain o...

FDA General

FDA Rehiring Freedom of Information Staff

FDA rehires some Freedom of Information office workers who were terminated under White House-mandated reduction-in-force cuts.

latest-news-card-1
Human Drugs

Vanda Tradipitant Scheduling Order Out

The FDA Office of Scientific Integrity publishes a scheduling order for Vandas request for a hearing on a proposed CDER order to deny approval of the ...

latest-news-card-1
FDA General

FDA Rehiring Some Travel Support Staff

The Associated Press reports FDA is attempting to rehire some travel support, food scientist, and Freedom of Information Act staff who were fired in r...

latest-news-card-1
Medical Devices

FDA Approves Element Science Wearable Defibrillator

FDA approves the Element Science PMA for its Jewel Patch wearable cardioverter defibrillator.

Medical Devices

Edwards Expands SAPIEN for Asymptomatic Patients

FDA approves Edwards Lifesciences' SAPIEN 3 transcatheter aortic valve replacement platform for patients with severe aortic stenosis who show no sympt...

latest-news-card-1
Human Drugs

Semaglutide Wins in Steatohepatitis, Fibrosis

A Phase 3 trial funded by Novo Nordisk showed that its Ozempic/Wegovy outperformed placebo in patients with steatohepatitis and fibrosis.

latest-news-card-1

Drug Safety Monitoring Hurt by FDA Staff Cuts: Post

Chemistry & Engineering News reports that reductions in CDER Division of Drug Information staff are affecting FDAs ability to maintain databases and r...

Biologics

Placebo-controlled Trials Needed for Vaccines: HHS

A self-described radical HHS policy now requires all new vaccines to be evaluated in placebo-controlled trials before theyre licensed for use, and thi...